NVCR
NovoCure Limited Ordinary Shares
$14.84
-2.56%
-0.39
Notify me if price changes either direction
Buy NVCR stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.7B
Enterprise value
1.6B
Trailing PE
-12.163934551302
Forward PE
-16.721312
PEG Ratio
0.19039201906385
Enterprise to EBITDA
-11.458
Enterprise to revenue
2.235
Price to book MRQ
5.3590193
Price to sales TTM
2.548111
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Revenue (TTM)
699.2M
EBITDA
-136392992
Diluted EPS TTM
-1.3
Total Cash (MRQ)
440.6M
Current ratio (MRQ)
2.893
Operating Cash Flow (TTM)
-2815000
NVCR trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
